Imagining a critical theory of change: making an impact on real world problems

The failure to address the world’s most pressing problems comes at a huge cost in terms of the catastrophic harm and destruction caused to humans and the natural environment. Although there are numerous pressing problems to deal with across society, the ‘grand problem’, or overarching ‘meta-problem’, is society’s inability to find more effective approaches to bring about the change required to materially reduce suffering, harm and destruction. This paper critically theorises social problems and social change as well as providing a critique of the current failing approaches deployed to realise change. The paper concludes by describing a critically informed approach to progressive social science knowledge making

A Workplace Dignity Perspective on Resilience: Moving beyond Individualized Instrumentalization to Dignified Resilience

Problem Resilience discourses in society and the contemporary workplace tend to emphasize the self-directed nature of resilience and the imposed demand for resilience for survival in the contemporary labor market. Solution In this article, the anchoring point of resilience is analyzed when conceptualized within a neoliberal and self-directed ideology. Subsequently, it offers an alternative anchoring point through a dignity-perspective on resilience, through which the term is reinterpreted in a new meaning. Stakeholders This article offers scholars, practitioners and policy-makers insights into how resilience can be conceptualized and used in practice. Analyzing resilience through a dignity lens provides new meanings and more effective uses of resilience in society and the contemporary workplaces

Imagining A Responsible Business School

This paper argues that business schools must go further than simply embedding climate change knowledge in the curriculum. Instead a genuinely responsible a business school has to undergo a radical transformation to embed human and planetary health as its primary purpose

The absurd workplace: How absurdity is hypernormalized in contemporary society and organizations

This paper examines absurdities in contemporary society and workplaces. Absurdity arises from the absence of rationality, where observed human practices paradoxically veer away from official discourse and institutional rhetoric. Absurdity does not exist in a vacuum but is penetrated by and hypernormalized through internalized societal ideologies. Hypernormalization, or the normalization of absurdity, was originally coined by Russian-born anthropologist Yurchak (2003, 2005) to understand the split between ideological, authoritative discourse and practice in the last decades of the Soviet Union. We extend the understanding of hypernormalization to describe how contemporary absurdities are normalized both in society and organizations. Moreover, we explain how hypernormalization unfolds at collective and individual levels through ideological fantasy and internalization. Fantasmatic investment and internalization enable individuals to manage the absurdities arising from the perpetual gap between authoritative discourse (e.g., companies’ commitment to climate action) and actual day-to-day practices (e.g., companies’ continued investment in fossil fuels). We finish by presenting three interrelated steps through which resistance, as a mechanism to deal with hypernormalization, emerges: problematization, resistance and imagination. We contribute to the literature by showing how these three ways may offer a way out of hypernormalization in society and workplaces

Abdominal cancer symptoms: evaluation of the impact of a regional public awareness campaign.

Objective: A regional ‘Be Clear on Cancer’ (BCoC) campaign developed by Public Health England aimed to promote public awareness of key abdominal cancer symptoms in people aged 50 years and over. Methods: Data were analysed for metrics at different stages in the patient care pathway including public awareness, GP attendance and referrals, to cancer diagnosis. Results: There was significantly higher recognition of the BCoC abdominal campaign in the campaign region compared to the control area (Post Campaign/Control, n = 401/406; 35% vs. 24%, p [less than] 0.05). The campaign significantly improved knowledge of ‘bloating’ as a symptom (p = 0.03) compared to pre-campaign levels. GP attendances for abdominal symptoms increased significantly by 5.8% (p = 0. 03), although the actual increase per practice was small (average 16.8 visits per week in 2016 to 17.7 in 2017). Urgent GP referrals for suspected abdominal cancer increased by 7.6%, compared to a non-significant change (0.05%) in the control area. For specific abdominal cancers, the number diagnosed were similar to or higher than the median in the campaign area but not in the control area in people aged 50 and over: colorectal (additional n = 61 cancers), pancreatic (additional n = 102) and stomach cancers (additional n = 17). Conclusions: This campaign had a modest impact on public awareness of abdominal cancer symptoms, GP attendances and cancers diagnosed

The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients

Background Participation in low-dose CT (LDCT) lung cancer screening offered in the trial context has been poor, especially among smokers from socioeconomically deprived backgrounds; a group for whom the risk-benefit ratio is improved due to their high risk of lung cancer. Attracting high risk participants is essential to the success and equity of any future screening programme. This study will investigate whether the observed low and biased uptake of screening can be improved using a targeted invitation strategy. Methods/design A randomised controlled trial design will be used to test whether targeted invitation materials are effective at improving engagement with an offer of lung cancer screening for high risk candidates. Two thousand patients aged 60–75 and recorded as a smoker within the last five years by their GP, will be identified from primary care records and individually randomised to receive either intervention invitation materials (which take a targeted, stepped and low burden approach to information provision prior to the appointment) or control invitation materials. The primary outcome is uptake of a nurse-led ‘lung health check’ hospital appointment, during which patients will be offered a spirometry test, an exhaled carbon monoxide (CO) reading, and an LDCT if eligible. Initial data on demographics (i.e. age, sex, ethnicity, deprivation score) and smoking status will be collected in primary care and analysed to explore differences between attenders and non-attenders with respect to invitation group. Those who attend the lung health check will have further data on smoking collected during their appointment (including pack-year history, nicotine dependence and confidence to quit). Secondary outcomes will include willingness to be screened, uptake of LDCT and measures of informed decision-making to ensure the latter is not compromised by either invitation strategy. Discussion If effective at improving informed uptake of screening and reducing bias in participation, this invitation strategy could be adopted by local screening pilots or a national programme. Trial registration This study was registered with the ISRCTN (International Standard Registered Clinical/soCial sTudy Number : ISRCTN21774741) on the 23rd September 2015 and the NIH ClinicalTrials.gov database (NCT0255810) on the 22nd September 2015

Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource

Objective: Thiopurines are widely used as maintenance therapy in inflammatory bowel disease (IBD) but the evidence base for their use is sparse and their role increasingly questioned. Using the largest series reported to date, we assessed the long-term effectiveness of thiopurines in ulcerative colitis (UC) and Crohn’s disease (CD), including their impact on need for surgery. Design: Outcomes were assessed in 11 928 patients (4968 UC, 6960 CD) in the UK IBD BioResource initiated on thiopurine monotherapy with the intention of maintaining medically induced remission. Effectiveness was assessed retrospectively using patient-level data and a definition that required avoidance of escalation to biological therapy or surgery while on thiopurines. Analyses included overall effectiveness, time-to-event analysis for treatment escalation and comparison of surgery rates in patients tolerant or intolerant of thiopurines. Results: Using 68 132 patient-years of exposure, thiopurine monotherapy appeared effective for the duration of treatment in 2617/4968 (52.7%) patients with UC compared with 2378/6960 (34.2%) patients with CD (p<0.0001). This difference was corroborated in a multivariable analysis: after adjusting for variables including treatment era, thiopurine monotherapy was less effective in CD than UC (OR 0.47, 95% CI 0.43 to 0.51, p<0.0001). Thiopurine intolerance was associated with increased risk of surgery in UC (HR 2.44, p<0.0001); with a more modest impact on need for surgery in CD (HR=1.23, p=0.0015). Conclusion: Thiopurine monotherapy is an effective long-term treatment for UC but significantly less effective in CD

HLA-DQA1*05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn's Disease

Anti-tumor necrosis factor (anti-TNF) therapies are the most widely used biologic drugs for treating immune-mediated diseases, but repeated administration can induce the formation of anti-drug antibodies. The ability to identify patients at increased risk for development of anti-drug antibodies would facilitate selection of therapy and use of preventative strategies.This article is freely available via Open Access. Click on Publisher URL to access the full-text

Manifesto for the future of work and organizational psychology

This manifesto presents 10 recommendations for a sustainable future for the field of Work and Organizational Psychology. The manifesto is the result of an emerging movement around the Future of WOP (seewww.futureofwop.com), which aims to bring together WOP-scholars committed to actively contribute to building a better future for our field. Our recommendations are intended to support both individuals and collectives to become actively engaged in co-creating the future of WOP together with us. Therefore, this manifesto is openand never“finished.”It should continuously evolve, based on an ongoing debate around our professional values and behavior. This manifesto is meant, first of all, for ourselves as an academic community. Furthermore, it is also important for managers, decision makers, and other stakeholders and interested parties,such as students, governments and organizations, as we envision what the future of WOP could look like, and it is only through our collective efforts that we will be able to realize a sustainable future for all of us